Celltrion
068270.KS
#755
Rank
A$46.52 B
Marketcap
A$212.67
Share price
1.40%
Change (1 day)
13.71%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.71. In 2024 the company made an earnings per share (EPS) of A$1.92 a decrease over its 2023 EPS that were of A$3.81.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$2.8849.73%
2024A$1.92-49.57%
2023A$3.81-2.08%
2022A$3.89-11.72%
2021A$4.412.03%
2020A$4.3282.8%
2019A$2.3718.31%
2018A$2.00-36.33%
2017A$3.14161.25%
2016A$1.202.86%
2015A$1.1717.84%
2014A$0.995.87%
2013A$0.94-70.85%
2012A$3.21134.09%
2011A$1.3743.59%
2010A$0.9674.49%
2009A$0.55317.8%
2008A$0.13-71.7%
2007A$0.46